PMID: 9163350Apr 15, 1997Paper

Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC

The Biochemical Journal
P H JensenRoss Jakes

Abstract

NAC, a 35-residue peptide derived from the neuronal protein alpha-synuclein/NAC precursor, is tightly associated with Abeta fibrils in Alzheimer's disease amyloid, and alpha-synuclein has recently been shown to bind Abeta in vitro. We have studied the interaction between Abeta and synucleins, aiming at determining segments in alpha-synuclein that can account for the binding, as well as identifying a possible interaction between Abeta and the beta-type synuclein. We report that Abeta binds to native and recombinant alpha-synuclein, and to beta-synuclein in an SDS-sensitive interaction (IC50 approx. 20 microM), as determined by chemical cross-linking and solid-phase binding assays. alpha-Synuclein and beta-synuclein were found to stimulate Abeta-aggregation in vitro to the same extent. The synucleins also displayed Abeta-inhibitable binding of NAC and they were capable of forming dimers. Using proteolytic fragmentation of alpha-synuclein and cross-linking to 125I-Abeta, we identified two consecutive binding domains (residues 1-56 and 57-97) by Edman degradation and mass spectrometric analysis, and a synthetic peptide comprising residues 32-57 possessed Abeta-binding activity. To test further the possible significance in pathology...Continue Reading

Citations

Sep 29, 1998·Genome Research·C Lavedan
Apr 20, 2001·The Journal of Biological Chemistry·M S NielsenP H Jensen
Jul 6, 2004·The Journal of Biological Chemistry·Yong ZhouJing Zhang
Jan 4, 2015·The Journal of Biological Chemistry·Mari H SavolainenHenri J Huttunen
May 4, 2017·Physiology and Molecular Biology of Plants : an International Journal of Functional Plant Biology·Lei LingChanghong Guo
Aug 21, 2020·Learning & Memory·Jack T Rogers, Catherine M Cahill
Oct 9, 2001·The Journal of Biological Chemistry·R Bussell, D Eliezer
Oct 12, 1999·Brain Pathology·M Hashimoto, E Masliah
Oct 3, 1999·The Journal of Biological Chemistry·M HashimotoE Masliah
Jun 8, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Mar 11, 2009·Antioxidants & Redox Signaling·Saurabh Sen, Andrew B West
Oct 31, 2014·International Journal of Molecular Medicine·Akari MinamiYasunori Ogura
Oct 22, 2016·Journal of Alzheimer's Disease : JAD·Yuta YoshinoShu-Ichi Ueno
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F J LeeH B Niznik
Mar 9, 2005·Journal of Neuropathology and Experimental Neurology·Irina MikolaenkoJuan C Troncoso
Oct 27, 2004·Cell and Tissue Research·Oliver von Bohlen Und Halbach
Jul 13, 2017·Proceedings of the National Academy of Sciences of the United States of America·Sean ChiaMichele Vendruscolo
Apr 30, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Somin KwonEliezer Masliah
Jan 9, 2004·The Journal of Biological Chemistry·Evo LinderssonPoul H Jensen
Jul 4, 2001·Journal of Neuroscience Research·A SurguchovI Surgucheva
May 3, 2005·The Journal of Biological Chemistry·Jee Young SungKwang Chul Chung
Dec 14, 2004·The Journal of Biological Chemistry·Evo LinderssonPoul Henning Jensen
Jun 23, 2015·Nature Medicine·Teresa BachhuberMelanie Meyer-Luehmann
Dec 6, 2020·International Journal of Biological Macromolecules·Hossein AshrafianRizwan Hasan Khan
Mar 7, 2021·Biomolecules·Jianshe WeiMakoto Hashimoto
Feb 13, 2001·Biochemical and Biophysical Research Communications·T NakamuraS Nakamura
Feb 2, 1999·Experimental Cell Research·N N NinkinaV L Buchman
Sep 27, 2000·Biochimica Et Biophysica Acta·H J ShinS R Paik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.